https://stock.noler.com/us/stock/cascadian-therapeutics-inc https://stock.noler.com/us/stock/cascadian-therapeutics-inc/accounts-and-other-receivables-net-current https://stock.noler.com/us/stock/cascadian-therapeutics-inc/accounts-payable https://stock.noler.com/us/stock/cascadian-therapeutics-inc/accretion-amortization-of-discounts-and-premiums-investments https://stock.noler.com/us/stock/cascadian-therapeutics-inc/accrued-liabilities-current https://stock.noler.com/us/stock/cascadian-therapeutics-inc/accumulated-depreciation https://stock.noler.com/us/stock/cascadian-therapeutics-inc/accumulated-oci-available-for-sale-adjustment-net-of-tax https://stock.noler.com/us/stock/cascadian-therapeutics-inc/accumulated-oci-foreign-currency-translation-adjustment-net-of-tax https://stock.noler.com/us/stock/cascadian-therapeutics-inc/additional-paid-in-capital https://stock.noler.com/us/stock/cascadian-therapeutics-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/cascadian-therapeutics-inc/amortization-of-financing-costs-and-discounts https://stock.noler.com/us/stock/cascadian-therapeutics-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/cascadian-therapeutics-inc/aoci https://stock.noler.com/us/stock/cascadian-therapeutics-inc/assets-fair-value-disclosure https://stock.noler.com/us/stock/cascadian-therapeutics-inc/available-for-sale-accumulated-gross-unrealized-gain-before-tax https://stock.noler.com/us/stock/cascadian-therapeutics-inc/available-for-sale-accumulated-gross-unrealized-loss-before-tax https://stock.noler.com/us/stock/cascadian-therapeutics-inc/available-for-sale-amortized-cost https://stock.noler.com/us/stock/cascadian-therapeutics-inc/available-for-sale-change-in-net-unrealized-holding-gain-loss-net-of-tax https://stock.noler.com/us/stock/cascadian-therapeutics-inc/available-for-sale-debt-amortized-cost-basis https://stock.noler.com/us/stock/cascadian-therapeutics-inc/available-for-sale-debt-gross-unrealized-gain https://stock.noler.com/us/stock/cascadian-therapeutics-inc/available-for-sale-debt-gross-unrealized-loss https://stock.noler.com/us/stock/cascadian-therapeutics-inc/available-for-sale-debt-maturities-after-one-through-five-years-amortized-cost https://stock.noler.com/us/stock/cascadian-therapeutics-inc/available-for-sale-debt-maturities-after-one-through-five-years-fair-value https://stock.noler.com/us/stock/cascadian-therapeutics-inc/available-for-sale-debt-maturities-amortized-cost https://stock.noler.com/us/stock/cascadian-therapeutics-inc/available-for-sale-debt-maturities-next-rolling-twelve-months-fair-value https://stock.noler.com/us/stock/cascadian-therapeutics-inc/available-for-sale-debt-maturities-rolling-year-two-through-five-fair-value https://stock.noler.com/us/stock/cascadian-therapeutics-inc/available-for-sale-debt-maturities-single-maturity-date https://stock.noler.com/us/stock/cascadian-therapeutics-inc/available-for-sale-debt-maturities-single-maturity-date-amortized-cost-basis https://stock.noler.com/us/stock/cascadian-therapeutics-inc/available-for-sale-debt-maturities-within-one-year-amortized-cost https://stock.noler.com/us/stock/cascadian-therapeutics-inc/available-for-sale-debt-maturities-within-one-year-fair-value https://stock.noler.com/us/stock/cascadian-therapeutics-inc/available-for-sale-debt-securities https://stock.noler.com/us/stock/cascadian-therapeutics-inc/available-for-sale-fair-value-disclosure https://stock.noler.com/us/stock/cascadian-therapeutics-inc/available-for-sale-gross-realized-gain-loss-net https://stock.noler.com/us/stock/cascadian-therapeutics-inc/available-for-sale-gross-unrealized-gain https://stock.noler.com/us/stock/cascadian-therapeutics-inc/available-for-sale-gross-unrealized-losses https://stock.noler.com/us/stock/cascadian-therapeutics-inc/available-for-sale-securities https://stock.noler.com/us/stock/cascadian-therapeutics-inc/available-for-sale-unrealized-loss-position-fair-value https://stock.noler.com/us/stock/cascadian-therapeutics-inc/available-for-sale-unrealized-loss-position-loss https://stock.noler.com/us/stock/cascadian-therapeutics-inc/basic-shares https://stock.noler.com/us/stock/cascadian-therapeutics-inc/capital-expenditures https://stock.noler.com/us/stock/cascadian-therapeutics-inc/cash https://stock.noler.com/us/stock/cascadian-therapeutics-inc/cash-acquired-from-acquisition https://stock.noler.com/us/stock/cascadian-therapeutics-inc/cash-and-equivalents https://stock.noler.com/us/stock/cascadian-therapeutics-inc/cash-flow-breakdown https://stock.noler.com/us/stock/cascadian-therapeutics-inc/certificates-of-deposit-at-carrying-value https://stock.noler.com/us/stock/cascadian-therapeutics-inc/class-of-warrant-or-right-exercise-price-of-warrants-or-rights https://stock.noler.com/us/stock/cascadian-therapeutics-inc/class-of-warrant-or-right-exercise-price-of-warrants-or-rights-1 https://stock.noler.com/us/stock/cascadian-therapeutics-inc/class-of-warrant-or-right-number-of-securities-called-by-warrants-or-rights https://stock.noler.com/us/stock/cascadian-therapeutics-inc/class-of-warrant-or-right-outstanding https://stock.noler.com/us/stock/cascadian-therapeutics-inc/commitments-and-contingencies https://stock.noler.com/us/stock/cascadian-therapeutics-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/cascadian-therapeutics-inc/common-stock-value https://stock.noler.com/us/stock/cascadian-therapeutics-inc/comprehensive-income https://stock.noler.com/us/stock/cascadian-therapeutics-inc/concept-stock-issued-tag-2 https://stock.noler.com/us/stock/cascadian-therapeutics-inc/contracts-revenue https://stock.noler.com/us/stock/cascadian-therapeutics-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/cascadian-therapeutics-inc/current-assets https://stock.noler.com/us/stock/cascadian-therapeutics-inc/current-federal-tax-expense-benefit https://stock.noler.com/us/stock/cascadian-therapeutics-inc/current-liabilities https://stock.noler.com/us/stock/cascadian-therapeutics-inc/debt-face-amount https://stock.noler.com/us/stock/cascadian-therapeutics-inc/debt-interest-rate-stated-percentage https://stock.noler.com/us/stock/cascadian-therapeutics-inc/debt-periodic-payment-principal https://stock.noler.com/us/stock/cascadian-therapeutics-inc/debt-unamortized-discount https://stock.noler.com/us/stock/cascadian-therapeutics-inc/deferred-compensation-arrangement-with-individual-contributions-by-employer https://stock.noler.com/us/stock/cascadian-therapeutics-inc/deferred-compensation-arrangement-with-individual-employer-contribution https://stock.noler.com/us/stock/cascadian-therapeutics-inc/deferred-income-tax-expense-benefit https://stock.noler.com/us/stock/cascadian-therapeutics-inc/deferred-income-tax-liabilities https://stock.noler.com/us/stock/cascadian-therapeutics-inc/deferred-rent-credit-current https://stock.noler.com/us/stock/cascadian-therapeutics-inc/deferred-rent-credit-noncurrent https://stock.noler.com/us/stock/cascadian-therapeutics-inc/deferred-revenue https://stock.noler.com/us/stock/cascadian-therapeutics-inc/deferred-revenue-noncurrent https://stock.noler.com/us/stock/cascadian-therapeutics-inc/deferred-revenue-revenue-recognized https://stock.noler.com/us/stock/cascadian-therapeutics-inc/deferred-tax-assets-goodwill-and-intangible-assets https://stock.noler.com/us/stock/cascadian-therapeutics-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/cascadian-therapeutics-inc/deferred-tax-assets-gross-noncurrent https://stock.noler.com/us/stock/cascadian-therapeutics-inc/deferred-tax-assets-liabilities-net-noncurrent https://stock.noler.com/us/stock/cascadian-therapeutics-inc/deferred-tax-assets-net https://stock.noler.com/us/stock/cascadian-therapeutics-inc/deferred-tax-assets-net-current https://stock.noler.com/us/stock/cascadian-therapeutics-inc/deferred-tax-assets-other https://stock.noler.com/us/stock/cascadian-therapeutics-inc/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/cascadian-therapeutics-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-accrued-liabilities https://stock.noler.com/us/stock/cascadian-therapeutics-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/cascadian-therapeutics-inc/deferred-tax-assets-valuation-allowance-noncurrent https://stock.noler.com/us/stock/cascadian-therapeutics-inc/deferred-tax-liabilities https://stock.noler.com/us/stock/cascadian-therapeutics-inc/deferred-tax-liabilities-current https://stock.noler.com/us/stock/cascadian-therapeutics-inc/deferred-tax-liabilities-goodwill-and-intangible-assets-intangible-assets https://stock.noler.com/us/stock/cascadian-therapeutics-inc/deferred-tax-liabilities-noncurrent https://stock.noler.com/us/stock/cascadian-therapeutics-inc/deferred-tax-liabilities-prepaid-expenses https://stock.noler.com/us/stock/cascadian-therapeutics-inc/depreciation-and-amortization https://stock.noler.com/us/stock/cascadian-therapeutics-inc/diluted-shares https://stock.noler.com/us/stock/cascadian-therapeutics-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/cascadian-therapeutics-inc/effective-tax-rate https://stock.noler.com/us/stock/cascadian-therapeutics-inc/employee-related-liabilities-current https://stock.noler.com/us/stock/cascadian-therapeutics-inc/employee-related-liabilities-current-and-noncurrent https://stock.noler.com/us/stock/cascadian-therapeutics-inc/eps https://stock.noler.com/us/stock/cascadian-therapeutics-inc/eps-basic https://stock.noler.com/us/stock/cascadian-therapeutics-inc/extinguishment-of-debt-amount https://stock.noler.com/us/stock/cascadian-therapeutics-inc/extinguishment-of-debt-gain-loss-net-of-tax https://stock.noler.com/us/stock/cascadian-therapeutics-inc/fair-value-adjustment-of-warrants https://stock.noler.com/us/stock/cascadian-therapeutics-inc/financing-cash-flow https://stock.noler.com/us/stock/cascadian-therapeutics-inc/foreign-currency-transaction-gain-loss-before-tax https://stock.noler.com/us/stock/cascadian-therapeutics-inc/form-d-other https://stock.noler.com/us/stock/cascadian-therapeutics-inc/form-d-stocks https://stock.noler.com/us/stock/cascadian-therapeutics-inc/gain-loss-on-disposition-of-property https://stock.noler.com/us/stock/cascadian-therapeutics-inc/gain-loss-on-sale-of-property-plant-equipment https://stock.noler.com/us/stock/cascadian-therapeutics-inc/gains-losses-on-extinguishment-of-debt https://stock.noler.com/us/stock/cascadian-therapeutics-inc/general-and-administrative-expense https://stock.noler.com/us/stock/cascadian-therapeutics-inc/goodwill https://stock.noler.com/us/stock/cascadian-therapeutics-inc/goodwill-impairment-loss https://stock.noler.com/us/stock/cascadian-therapeutics-inc/grants-receivable https://stock.noler.com/us/stock/cascadian-therapeutics-inc/impairment-of-intangible-assets-excluding-goodwill https://stock.noler.com/us/stock/cascadian-therapeutics-inc/impairment-of-intangible-assets-indefinitelived-excluding-goodwill https://stock.noler.com/us/stock/cascadian-therapeutics-inc/impairment-of-long-lived-assets-held-for-use https://stock.noler.com/us/stock/cascadian-therapeutics-inc/income-loss-from-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/cascadian-therapeutics-inc/income-tax https://stock.noler.com/us/stock/cascadian-therapeutics-inc/income-tax-expense-benefit-adjustment-of-deferred-tax-asset-liability https://stock.noler.com/us/stock/cascadian-therapeutics-inc/income-taxes-paid https://stock.noler.com/us/stock/cascadian-therapeutics-inc/increase-decrease-in-accounts-and-other-receivables https://stock.noler.com/us/stock/cascadian-therapeutics-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/cascadian-therapeutics-inc/increase-decrease-in-accrued-liabilities https://stock.noler.com/us/stock/cascadian-therapeutics-inc/increase-decrease-in-deferred-revenue https://stock.noler.com/us/stock/cascadian-therapeutics-inc/increase-decrease-in-employee-related-liabilities https://stock.noler.com/us/stock/cascadian-therapeutics-inc/increase-decrease-in-other-current-assets https://stock.noler.com/us/stock/cascadian-therapeutics-inc/increase-decrease-in-other-deferred-liability https://stock.noler.com/us/stock/cascadian-therapeutics-inc/increase-decrease-in-other-noncurrent-assets https://stock.noler.com/us/stock/cascadian-therapeutics-inc/increase-decrease-in-other-noncurrent-liabilities https://stock.noler.com/us/stock/cascadian-therapeutics-inc/increase-decrease-in-other-receivables https://stock.noler.com/us/stock/cascadian-therapeutics-inc/increase-decrease-in-prepaid-expense https://stock.noler.com/us/stock/cascadian-therapeutics-inc/incremental-common-shares-attributable-to-share-based-payment-arrangements https://stock.noler.com/us/stock/cascadian-therapeutics-inc/indefinite-lived-intangible-assets-excluding-goodwill https://stock.noler.com/us/stock/cascadian-therapeutics-inc/insider-transactions-other https://stock.noler.com/us/stock/cascadian-therapeutics-inc/insider-transactions-preferred https://stock.noler.com/us/stock/cascadian-therapeutics-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/cascadian-therapeutics-inc/insider-transactions-stock-units https://stock.noler.com/us/stock/cascadian-therapeutics-inc/insider-transactions-warrants https://stock.noler.com/us/stock/cascadian-therapeutics-inc/interest-expense https://stock.noler.com/us/stock/cascadian-therapeutics-inc/interest-expense-on-debt https://stock.noler.com/us/stock/cascadian-therapeutics-inc/interest-paid https://stock.noler.com/us/stock/cascadian-therapeutics-inc/investing-cash-flow https://stock.noler.com/us/stock/cascadian-therapeutics-inc/investment-income-net https://stock.noler.com/us/stock/cascadian-therapeutics-inc/leasehold-improvements-gross https://stock.noler.com/us/stock/cascadian-therapeutics-inc/licenses-revenue https://stock.noler.com/us/stock/cascadian-therapeutics-inc/line-of-credit-facility-maximum-borrowing-capacity https://stock.noler.com/us/stock/cascadian-therapeutics-inc/long-term-investments https://stock.noler.com/us/stock/cascadian-therapeutics-inc/long-term-notes-payable https://stock.noler.com/us/stock/cascadian-therapeutics-inc/maturities-of-shortterm-investments https://stock.noler.com/us/stock/cascadian-therapeutics-inc/money-market-funds-at-carrying-value https://stock.noler.com/us/stock/cascadian-therapeutics-inc/net-cash-from-financing-activities https://stock.noler.com/us/stock/cascadian-therapeutics-inc/net-cash-from-investing-activities https://stock.noler.com/us/stock/cascadian-therapeutics-inc/net-cash-from-operating-activities https://stock.noler.com/us/stock/cascadian-therapeutics-inc/net-change-in-cash https://stock.noler.com/us/stock/cascadian-therapeutics-inc/net-income https://stock.noler.com/us/stock/cascadian-therapeutics-inc/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/cascadian-therapeutics-inc/net-income-loss-available-to-common-stockholders-diluted https://stock.noler.com/us/stock/cascadian-therapeutics-inc/notes-payable-current https://stock.noler.com/us/stock/cascadian-therapeutics-inc/number-of-operating-segments https://stock.noler.com/us/stock/cascadian-therapeutics-inc/oci-available-for-sale-adjustment-net-of-tax https://stock.noler.com/us/stock/cascadian-therapeutics-inc/oci-available-for-sale-adjustment-net-of-tax-change https://stock.noler.com/us/stock/cascadian-therapeutics-inc/oci-foreign-currency-translation-gain-loss-arising-tax https://stock.noler.com/us/stock/cascadian-therapeutics-inc/oci-net-of-tax https://stock.noler.com/us/stock/cascadian-therapeutics-inc/oci-net-of-tax-2 https://stock.noler.com/us/stock/cascadian-therapeutics-inc/oci-net-of-tax-change https://stock.noler.com/us/stock/cascadian-therapeutics-inc/oci-reclassification-adjustment-from-aoci-for-sale-of-securities-before-tax https://stock.noler.com/us/stock/cascadian-therapeutics-inc/oci-reclassification-adjustment-from-aoci-for-sale-of-securities-net-of-tax https://stock.noler.com/us/stock/cascadian-therapeutics-inc/oci-securities-sale-reclassification-net-of-tax https://stock.noler.com/us/stock/cascadian-therapeutics-inc/oci-unrealized-holding-gain-loss-on-securities-arising-net-of-tax https://stock.noler.com/us/stock/cascadian-therapeutics-inc/operating-cash-flow https://stock.noler.com/us/stock/cascadian-therapeutics-inc/operating-expenses https://stock.noler.com/us/stock/cascadian-therapeutics-inc/operating-income https://stock.noler.com/us/stock/cascadian-therapeutics-inc/operating-lease-payments-due https://stock.noler.com/us/stock/cascadian-therapeutics-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/cascadian-therapeutics-inc/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/cascadian-therapeutics-inc/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/cascadian-therapeutics-inc/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/cascadian-therapeutics-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/cascadian-therapeutics-inc/operating-lease-payments-due-thereafter https://stock.noler.com/us/stock/cascadian-therapeutics-inc/operating-leases-rent-expense-net https://stock.noler.com/us/stock/cascadian-therapeutics-inc/operating-loss-carryforwards https://stock.noler.com/us/stock/cascadian-therapeutics-inc/other-asset-impairment-charges https://stock.noler.com/us/stock/cascadian-therapeutics-inc/other-current-assets https://stock.noler.com/us/stock/cascadian-therapeutics-inc/other-income https://stock.noler.com/us/stock/cascadian-therapeutics-inc/other-income-2 https://stock.noler.com/us/stock/cascadian-therapeutics-inc/other-labor-related-expenses https://stock.noler.com/us/stock/cascadian-therapeutics-inc/other-noncash-expense https://stock.noler.com/us/stock/cascadian-therapeutics-inc/other-noncash-income https://stock.noler.com/us/stock/cascadian-therapeutics-inc/other-noncash-income-expense https://stock.noler.com/us/stock/cascadian-therapeutics-inc/other-noncurrent-assets https://stock.noler.com/us/stock/cascadian-therapeutics-inc/other-noncurrent-liabilities https://stock.noler.com/us/stock/cascadian-therapeutics-inc/other-nonoperating-income-expense https://stock.noler.com/us/stock/cascadian-therapeutics-inc/other-tax-expense-benefit https://stock.noler.com/us/stock/cascadian-therapeutics-inc/paid-in-capital-shares-issued-issuance-costs https://stock.noler.com/us/stock/cascadian-therapeutics-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/cascadian-therapeutics-inc/paid-in-capital-warrant-issued https://stock.noler.com/us/stock/cascadian-therapeutics-inc/payments-for-proceeds-from-productive-assets https://stock.noler.com/us/stock/cascadian-therapeutics-inc/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/cascadian-therapeutics-inc/payments-to-acquire-investments https://stock.noler.com/us/stock/cascadian-therapeutics-inc/payments-to-acquire-short-term-investments https://stock.noler.com/us/stock/cascadian-therapeutics-inc/preferred-shares-facts https://stock.noler.com/us/stock/cascadian-therapeutics-inc/preferred-stock-liquidation-preference https://stock.noler.com/us/stock/cascadian-therapeutics-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/cascadian-therapeutics-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/cascadian-therapeutics-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/cascadian-therapeutics-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/cascadian-therapeutics-inc/preferred-stock-value https://stock.noler.com/us/stock/cascadian-therapeutics-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/cascadian-therapeutics-inc/prepaid-expense-current https://stock.noler.com/us/stock/cascadian-therapeutics-inc/pretax-income https://stock.noler.com/us/stock/cascadian-therapeutics-inc/pretax-income-minority-interest-and-income-loss-from-equity-method-investments https://stock.noler.com/us/stock/cascadian-therapeutics-inc/proceeds-from-collection-of-notes-receivable https://stock.noler.com/us/stock/cascadian-therapeutics-inc/proceeds-from-contributed-capital https://stock.noler.com/us/stock/cascadian-therapeutics-inc/proceeds-from-debt-net-of-issuance-costs https://stock.noler.com/us/stock/cascadian-therapeutics-inc/proceeds-from-issuance-of-convertible-preferred-stock https://stock.noler.com/us/stock/cascadian-therapeutics-inc/proceeds-from-issuance-or-sale-of-equity https://stock.noler.com/us/stock/cascadian-therapeutics-inc/proceeds-from-sale-maturity-and-collections-of-investments https://stock.noler.com/us/stock/cascadian-therapeutics-inc/proceeds-from-sale-of-available-for-sale-securities https://stock.noler.com/us/stock/cascadian-therapeutics-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/cascadian-therapeutics-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/cascadian-therapeutics-inc/proceeds-from-warrant-exercises https://stock.noler.com/us/stock/cascadian-therapeutics-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/cascadian-therapeutics-inc/property-plant-and-equipment-other-accumulated-depreciation https://stock.noler.com/us/stock/cascadian-therapeutics-inc/property-plant-and-equipment-other-net https://stock.noler.com/us/stock/cascadian-therapeutics-inc/property-plant-and-equipment-owned-accumulated-depreciation https://stock.noler.com/us/stock/cascadian-therapeutics-inc/property-plant-and-equipment-owned-net https://stock.noler.com/us/stock/cascadian-therapeutics-inc/property-plant-equipment https://stock.noler.com/us/stock/cascadian-therapeutics-inc/provision-for-doubtful-accounts https://stock.noler.com/us/stock/cascadian-therapeutics-inc/public-float https://stock.noler.com/us/stock/cascadian-therapeutics-inc/reclassification-from-accumulated-oci-current-period-net-of-tax https://stock.noler.com/us/stock/cascadian-therapeutics-inc/recognition-of-deferred-revenue https://stock.noler.com/us/stock/cascadian-therapeutics-inc/repayments-of-debt https://stock.noler.com/us/stock/cascadian-therapeutics-inc/repayments-of-notes-payable https://stock.noler.com/us/stock/cascadian-therapeutics-inc/research-and-development https://stock.noler.com/us/stock/cascadian-therapeutics-inc/retained-earnings https://stock.noler.com/us/stock/cascadian-therapeutics-inc/revenue https://stock.noler.com/us/stock/cascadian-therapeutics-inc/sale-of-stock-price-per-share https://stock.noler.com/us/stock/cascadian-therapeutics-inc/share-price https://stock.noler.com/us/stock/cascadian-therapeutics-inc/shareholders-equity https://stock.noler.com/us/stock/cascadian-therapeutics-inc/shares-authorized https://stock.noler.com/us/stock/cascadian-therapeutics-inc/shares-issued https://stock.noler.com/us/stock/cascadian-therapeutics-inc/shares-issued-shares-new-issues https://stock.noler.com/us/stock/cascadian-therapeutics-inc/shares-subject-to-mandatory-redemption-settlement-terms-amount https://stock.noler.com/us/stock/cascadian-therapeutics-inc/shares-subject-to-mandatory-redemption-settlement-terms-number-of-shares https://stock.noler.com/us/stock/cascadian-therapeutics-inc/short-term-investments https://stock.noler.com/us/stock/cascadian-therapeutics-inc/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/cascadian-therapeutics-inc/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/cascadian-therapeutics-inc/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/cascadian-therapeutics-inc/stock-award-maximum-number-of-shares-per-employee https://stock.noler.com/us/stock/cascadian-therapeutics-inc/stock-award-number-of-shares-available-for-grant https://stock.noler.com/us/stock/cascadian-therapeutics-inc/stock-award-rsu-grants-in-period https://stock.noler.com/us/stock/cascadian-therapeutics-inc/stock-award-rsu-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/cascadian-therapeutics-inc/stock-award-rsu-vested-in-period https://stock.noler.com/us/stock/cascadian-therapeutics-inc/stock-award-rsu-vested-in-period-grant-date-fair-value https://stock.noler.com/us/stock/cascadian-therapeutics-inc/stock-award-shares-issued-in-period https://stock.noler.com/us/stock/cascadian-therapeutics-inc/stock-based-compensation https://stock.noler.com/us/stock/cascadian-therapeutics-inc/stock-compensation-unrecognized-cost https://stock.noler.com/us/stock/cascadian-therapeutics-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/cascadian-therapeutics-inc/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/cascadian-therapeutics-inc/stock-issued-shares-issued-shares-conversion-of-convertible-securities https://stock.noler.com/us/stock/cascadian-therapeutics-inc/stock-issued-shares-issued-shares-espps https://stock.noler.com/us/stock/cascadian-therapeutics-inc/stock-issued-shares-issued-shares-restricted-stock-award-gross https://stock.noler.com/us/stock/cascadian-therapeutics-inc/stock-issued-shares-issued-value-espp https://stock.noler.com/us/stock/cascadian-therapeutics-inc/stock-issued-shares-issued-value-restricted-stock-award-gross https://stock.noler.com/us/stock/cascadian-therapeutics-inc/stock-issued-shares-issued-value-restricted-stock-award-net-of-forfeitures https://stock.noler.com/us/stock/cascadian-therapeutics-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/cascadian-therapeutics-inc/stock-issued-value-of-shares-issued-for-acquisitions https://stock.noler.com/us/stock/cascadian-therapeutics-inc/stock-options-exercises-in-period-total-intrinsic-value https://stock.noler.com/us/stock/cascadian-therapeutics-inc/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/cascadian-therapeutics-inc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/cascadian-therapeutics-inc/stock-options-vested-in-period-fair-value https://stock.noler.com/us/stock/cascadian-therapeutics-inc/stock-options-vested-in-period-fair-value-1 https://stock.noler.com/us/stock/cascadian-therapeutics-inc/stock-split-ratio https://stock.noler.com/us/stock/cascadian-therapeutics-inc/tax-credit-carryforward-deferred-tax-asset https://stock.noler.com/us/stock/cascadian-therapeutics-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/cascadian-therapeutics-inc/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/cascadian-therapeutics-inc/tax-rate-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/cascadian-therapeutics-inc/tax-rate-reconciliation-nondeductible-expense-share-based-compensation-cost https://stock.noler.com/us/stock/cascadian-therapeutics-inc/tax-rate-reconciliation-other-adjustments https://stock.noler.com/us/stock/cascadian-therapeutics-inc/total-assets https://stock.noler.com/us/stock/cascadian-therapeutics-inc/total-liabilities https://stock.noler.com/us/stock/cascadian-therapeutics-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/cascadian-therapeutics-inc/unrecognized-tax-benefits https://stock.noler.com/us/stock/cascadian-therapeutics-inc/utb-decrease-from-current-year-positions https://stock.noler.com/us/stock/cascadian-therapeutics-inc/utb-increase-from-prior-year-positions https://stock.noler.com/us/stock/cascadian-therapeutics-inc/utb-reduction-from-statute-lapse https://stock.noler.com/us/stock/cascadian-therapeutics-inc/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/cascadian-therapeutics-inc/weighted-average-number-of-share-outstanding-basic-and-diluted https://stock.noler.com/us/stock/cascadian-therapeutics-inc/weighted-average-number-of-shares-outstanding-basic-and-diluted